prader willi glp 1 for The effects of glucagon‐like peptide (GLP)‐1 receptor Severe respiratory complications in late-diagnosed

A daily tablet is far easier to keep on track when life is in motion

Although GLP-1s have only been FDA-approved within the last two decades, the science behind them dates back to the 1960s, when researchers discovered a family of hormones called incretins

Zepbound (tirzepatide) : A newer option that combines the effects of GLP-1 and GIP (gastric inhibitory polypeptide) to enhance weight loss results

By using lower doses than the standard escalation protocol, patients can stretch their medication supply and reduce monthly expenditure

Weight re-gain since discontinuation was significantly associated with reinitiation